BlueHQ: The colorectal cancer patient support hub
Take control of your path with colorectal cancer at BlueHQ, a free support service for patients and caregivers powered by the Colorectal Cancer Alliance.
BlueHQ is support magnified
BlueHQ is your digital hub with personalized resources, tools, and communities. You can:
- Explore personalized resources
- Connect with your community
- Track treatments and office visits
- Access support from the Alliance
BlueHQ has the information I need without searching. I can also connect with the Alliance’s support team and other patients like me.
Knowledge and tools curated for you
The path with colorectal cancer is different for every patient and caregiver. BlueHQ suggests helpful tools and resources that align with your story. Get the information that matters.
Connect with others who get it
BlueHQ connects you to thousands of allies with similar experiences. In this community, you can skip the basics and get to what matters — how to cope with colorectal cancer.
Keep track of important details
Store notes from your journey — including doctor visits, counseling sessions, and more — safely and securely. Or use BlueHQ as a journal. You can search your notes later.
Improve your journey with BlueHQ
Stay in the know about CRC resources and news, keep track of personalized medical information, and connect with a community of allies.
More Alliance communities
Get connectedTop resources
2025 ASCO update: Six big studies
The 2025 ASCO Annual Meeting featured several important studies that could change how colorectal cancer is treated, including a pivotal study for BRAF V600E patients.
Finding hope and healing with the Alliance
Discover hope and healing through Angela and Marleigh Cummins' powerful journey after losing Rodney to colorectal cancer. Learn how their partnership with the Colorectal Cancer Alliance turned grief into advocacy, raising awareness and fostering community support to take on colorectal cancer.
Hope in the Details: How Heather’s Biomarker Opened New Treatment Paths
After a stage IV colorectal cancer diagnosis, Heather’s biomarker test revealed a critical mutation — opening the door to clinical trials and new hope.